Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 15;22(12):2520-8.
doi: 10.1093/hmg/ddt086. Epub 2013 Mar 27.

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

Zsofia Kote-Jarai  1 Edward J SaundersDaniel A LeongamornlertMalgorzata TymrakiewiczTokhir DadaevSarah Jugurnauth-LittleHelen Ross-AdamsAli Amin Al OlamaSara BenllochSilvia HalimRoslin RussellAlison M DunningCraig LuccariniJoe DennisDavid E NealFreddie C HamdyJenny L DonovanKen MuirGraham G GilesGianluca SeveriFredrik WiklundHenrik GronbergChristopher A HaimanFredrick SchumacherBrian E HendersonLoic Le MarchandSara LindstromPeter KraftDavid J HunterSusan GapsturStephen ChanockSonja I BerndtDemetrius AlbanesGerald AndrioleJohanna SchleutkerMaren WeischerFederico CanzianElio RiboliTim J KeyRuth C TravisDaniele CampaSue A InglesEsther M JohnRichard B HayesPaul PharoahKay-Tee KhawJanet L StanfordElaine A OstranderLisa B SignorelloStephen N ThibodeauDan SchaidChristiane MaierWalther VogelAdam S KibelCezary CybulskiJan LubinskiLisa Cannon-AlbrightHermann BrennerJong Y ParkRadka KanevaJyotsna BatraAmanda SpurdleJudith A ClementsManuel R TeixeiraKoveela GovindasamiMichelle GuyRosemary A WilkinsonEmma J SawyerAngela MorganEd DicksCaroline BaynesDon ConroyStig E BojesenRudolf KaaksDaniel VincentFrançois BacotDaniel C TessierCOGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) InitiativeUK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of OncologyUK ProtecT Study CollaboratorsPRACTICAL ConsortiumDouglas F EastonRosalind A Eeles
Affiliations

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

Zsofia Kote-Jarai et al. Hum Mol Genet. .

Erratum in

  • Hum Mol Genet. 2013 Oct 15;22(20):4239. Russel, Roslin [corrected to Russell, Roslin]

Abstract

Associations between single nucleotide polymorphisms (SNPs) at 5p15 and multiple cancer types have been reported. We have previously shown evidence for a strong association between prostate cancer (PrCa) risk and rs2242652 at 5p15, intronic in the telomerase reverse transcriptase (TERT) gene that encodes TERT. To comprehensively evaluate the association between genetic variation across this region and PrCa, we performed a fine-mapping analysis by genotyping 134 SNPs using a custom Illumina iSelect array or Sequenom MassArray iPlex, followed by imputation of 1094 SNPs in 22 301 PrCa cases and 22 320 controls in The PRACTICAL consortium. Multiple stepwise logistic regression analysis identified four signals in the promoter or intronic regions of TERT that independently associated with PrCa risk. Gene expression analysis of normal prostate tissue showed evidence that SNPs within one of these regions also associated with TERT expression, providing a potential mechanism for predisposition to disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Results of TERT fine-mapping analysis. (A) Regional association plot of the imputed iCOGS genotype data. Typed SNPs are indicated in red and imputed SNPs in grey. Diamonds denote SNPs significantly associated with PrCa after multiple LR analyses. The 20 kb interval is denoted by the shaded region that is expanded below. Forty-four SNPs were associated with PrCa risk at P < 10−5 (indicated by the red line). (B) Expanded detail for the 20 kb interval. The positions of 42 SNPs located within this window significant at P < 10−5 are marked (42 SNPs P < 10−5), as are the 4 SNPs independently significant after multiple LR model and SNPs that overlap with ENCODE annotations (ENCODE intersect), including DNase I hypersensitivity (DNase Clusters) and TFBS ChIP signals. The positions of TERT gene transcripts from Ensembl 65 (TERT), CpG island regions (CpG), segmental duplications (SegDup) and ENCODE chromatin state (Broad ChromHmm) are also indicated. The light grey rectangle (Broad ChrommHmm) denotes a region of heterochromatin, the yellow rectangle a weak enhancer and the dark grey rectangle a polycomb-repressed region. All tracks were generated using the Hg19 build of the UCSC genome browser. The locations of regions 1–4 are indicated as coloured rectangles and numbered. (C) LD plot for the 20 kb interval. r2 values are derived from imputed data for the UKGPCS subset of iCOGS samples. Triangles indicate the boundaries of regions 1–4. MLR, multiple LR.
Figure 2.
Figure 2.
mRNA expression levels in benign prostate tissue for three SNPs in region 1 of the TERT locus. A significant increase in TERT expression was observed for the minor (protective) alleles of (A) rs10069690, (C) rs2242652 and (D) rs7725218. No effect on expression of the CLPTM1L gene was observed, data are shown only for (B) rs10069690.

Comment in

References

    1. Kote-Jarai Z., Al Olama A.A., Giles G.G., Severi G., Schleutker J., Weischer M., Campa D., Riboli E., Key T., Gronberg H., et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet. 2011;43:785–791. - PMC - PubMed
    1. Wyatt H.D., West S.C., Beattie T.L. InTERTpreting telomerase structure and function. Nucleic Acids Res. 2010;38:5609–5622. - PMC - PubMed
    1. Jang J.S., Choi Y.Y., Lee W.K., Choi J.E., Cha S.I., Kim Y.J., Kim C.H., Kam S., Jung T.H., Park J.Y. Telomere length and the risk of lung cancer. Cancer Sci. 2008;99:1385–1389. - PMC - PubMed
    1. Martinez-Delgado B., Yanowsky K., Inglada-Perez L., de la H.M., Caldes T., Vega A., Blanco A., Martin T., Gonzalez-Sarmiento R., Blasco M., et al. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J. Med. Genet. 2012;49:341–344. - PubMed
    1. Pooley K.A., Sandhu M.S., Tyrer J., Shah M., Driver K.E., Luben R.N., Bingham S.A., Ponder B.A., Pharoah P.D., Khaw K.T., et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010;70:3170–3176. - PMC - PubMed

Publication types